Katherine Phoenix Liao, M.D.
|Title||Assistant Professor of Medicine|
|Institution||Brigham and Women's Hospital|
|Address||Brigham and Women's Hospital|
Rheumatolgy - PBB-B3
75 Francis St
Boston MA 02115
(login for email)
Dr. Liao is a clinical investigator and practicing rheumatologist. The mission of her lab her lab is two-fold: (1) is to study rheumatoid arthritis (RA), and the clinical and genetic factors that lead to outcomes such as cardiovascular disease and severe joint damage, and (2) is to apply and develop bioinformatics methods to utilize big data for clinical and translational research studies. Dr. Liao’s research focuses on applying methods such as natural language processing to electronic medical record (EMR) data to perform clinical studies in RA and other conditions.
Heart disease is the leading cause of death in patients with RA. This high risk has been attributed to inflammation, which is an important risk factor for heart disease in the general population. Determining these links can identify strategies to reduce CV risk in RA, as well as lead to potential targets of treatment in the general population. Dr. Liao is the PI of the R01 funded study, Lipids, Inflammation and CV risk in RA (LiiRA). The goal of LiiRA is to investigate how inflammation may modify important traditional cardiovascular risk factors such as cholesterol and blood pressure, and the impact of these modifications on CV risk. She is also a co-investigator on an NIH U01 multi-center RCT, Treatment Against RA and Effect on FDG PET CT (TARGET). TARGET specifically tests the hypothesis that reducing inflammation, reduces vascular inflammation and CV risk in RA. In line with her research interests, Dr. Liao is co-Director of the Cardiovascular Rheumatology Clinic at Brigham and Women’s Hospital.
Through her work with the Informatics for Integrating Biology and the Bedside (i2b2) project, Dr. Liao led the team to develop an EMR research platform for RA studies. This platform integrated clinical and biomarker data (e.g. clinical EMR data, genetics, autoantibody data) allowing for both traditional genetic association studies as well as new approaches for data analyses such as the Phenome Wide Association Study (PheWAS). Using this platform, she collaborates closely with investigators from the fields of biostatistics and bioinformatics to apply novel methods to study focused clinical questions such as CVD in RA. Currently, she is leading a pilot project to port and further develop these methods at VA Boston Healthcare using nationwide VA data with a goal to establish an EMR research platform at the VA.
The research activities and funding listed below are automatically derived from
NIH ExPORTER and other sources, which might result in incorrect or missing items.
to make corrections and additions.
R01HL127118 (LIAO, KATHERINE PHOENIX)Apr 1, 2016 - Feb 28, 2021NIH/NHLBI
Lipids, Inflammation, and Cardiovascular Risk in Rheumatoid Arthritis
Role: Principal Investigator
K08AR060257 (LIAO, KATHERINE PHOENIX)Jul 15, 2011 - Jun 30, 2016NIH/NIAMS
Genetic Risk Factors for Coronary Artery Disease in Rheumatoid Arthritis
Role: Principal Investigator
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Click the "See All" links for more information and interactive visualizations!
People who are also in this person's primary department.